Medpace insider exercises 3,000 stock options

Medpace’s Executive VP of Operations exercised 3,000 stock options into common shares, raising her direct common stock holdings to 65,984 shares.

Available on EDGAR 09/17/2026 - 04:36 PM EDT Accepted by SEC EDGAR 09/17/2026 - 04:35 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Medpace Holdings, Inc. (MEDP) executive Susan E. Burwig, Executive Vice President of Operations, exercised employee stock options for 3,000 shares of common stock on September 15, 2026 at an exercise price of $166.73 per share. The option, which vested in full on October 27, 2025 and expires on October 27, 2026, was converted into common stock, increasing her directly held common shares to 65,984. Following this transaction she continues to hold 8,028 stock options directly, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

3,000 shares exercised/converted

Exercise 2 txns

Insider BURWIG SUSAN E

Role Exec. VP, Operations

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy) F1	3,000	$0.00	$0.00
Exercise	Common Stock	3,000	$166.73	$500K

Holdings After Transaction: Employee Stock Option (Right to Buy) — 8,028 contracts (Direct); Common Stock — 65,984 shares (Direct)

Holdings Before and After: Employee Stock Option (Right to Buy), 11,028 to 8,028 contracts (Direct); Common Stock, 62,984 to 65,984 shares (Direct)

Footnotes (1)

1. F1. The option vested in full on October 27, 2025.

Key Figures

Options exercised: 3,000 options Exercise price: $166.73 per share Common shares after transaction: 65,984 shares +4 more

7 metrics

Options exercised 3,000 options Employee stock options converted into common stock on September 15, 2026

Exercise price $166.73 per share Exercise price for 3,000 employee stock options

Common shares after transaction 65,984 shares Direct Medpace common stock holdings by Susan E. Burwig after the exercise

Options remaining after transaction 8,028 options Directly held employee stock options remaining after the reported exercise

Underlying shares exercised 3,000 shares Common shares issued upon option exercise on September 15, 2026

Option vesting date October 27, 2025 Date the exercised option vested in full

Option expiration date October 27, 2026 Expiration date for the exercised option grant

Key Terms

Employee Stock Option (Right to Buy), Common Stock, vested in full, expiration date

4 terms

Employee Stock Option (Right to Buy) financial

"Employee Stock Option (Right to Buy)"

Common Stock financial

"Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vested in full financial

"The option vested in full on October 27, 2025."

expiration date financial

"expiration date: 2026-10-27"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Medpace Holdings (MEDP) report for Susan E. Burwig?

Susan E. Burwig exercised 3,000 stock options for Medpace common stock on September 15, 2026, converting them into 3,000 shares of common stock at an exercise price of $166.73 per share.

How many Medpace (MEDP) common shares does Susan E. Burwig hold after this Form 4?

After the reported option exercise, Susan E. Burwig directly holds 65,984 shares of Medpace common stock, as disclosed in the filing for September 15, 2026.

What was the exercise price of the Medpace (MEDP) options exercised by Susan E. Burwig?

The employee stock options exercised by Susan E. Burwig on September 15, 2026 had an exercise price of $166.73 per share for 3,000 underlying shares of Medpace common stock.

Does the Medpace (MEDP) Form 4 indicate a Rule 10b5-1 trading plan for this transaction?

No. The filing indicates that no Rule 10b5-1 trading plan applies to the transactions reported for Susan E. Burwig on September 15, 2026.

What Medpace (MEDP) stock option position does Susan E. Burwig retain after this transaction?

Following the option exercise reported on September 15, 2026, Susan E. Burwig continues to hold 8,028 employee stock options directly, as stated in the filing’s post-transaction holdings.

When did the Medpace (MEDP) options exercised by Susan E. Burwig vest and when do they expire?

The employee stock option exercised for 3,000 shares vested in full on October 27, 2025 and carries an expiration date of October 27, 2026, as disclosed in the footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BURWIG SUSAN E

(Last) (First) (Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI OHIO 45227

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec. VP, Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2026		M		3,000	A	$166.73	65,984	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$166.73	09/15/2026		M			3,000	(1)	10/27/2026	Common Stock	3,000	$0	8,028	D

Explanation of Responses:

1. The option vested in full on October 27, 2025.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Susan E. Burwig	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)